Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2304 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2306 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2302 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2513-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-231 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2313 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate |
2016-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2018-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2018533728-A |
titleOfInvention |
Ex vivo methods for testing the cellular responsiveness of primary cell populations to drugs or drug combinations |
abstract |
The invention presented herein provides an artificial environment of a primary cell population, specifically a method of producing an artificial tumor environment of a primary tumor cell population, and cell responsiveness of the primary cell population to a drug or combination of drugs. It relates to its use in an ex vivo method for testing. The methods of the invention involve incubation of primary tumor cells with an artificial tumor environment and a drug to analyze the response of the primary tumor cell population. Incubation of primary tumor cells in an artificial tumor environment enhances the survival rate of said tumor cells and / or induces greater levels of tumor cell proliferation and, consequently, the sensitivity of the test for the drug to be analyzed And increase accuracy. 【Selection chart】 None |
priorityDate |
2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |